Skip to content

Author

L. Bulić

We have 1 of 31 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction

The current role of AI is summarized across the peptide cancer vaccine development pipeline, from neoantigen discovery and epitope prioritization to prediction of peptide–HLA binding, antigen presentation, and T-cell receptor recognition, and the application of modern computational frameworks.

P. Brlek, J. Kolić, L. Bulić et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.